Research Notes

A melanocortin-receptor agonist studied for sexual arousal — acting through the central nervous system, not blood flow. Mechanism, research areas, and status.

A Russian-developed ACTH-fragment peptide studied for focus, memory and neuroprotection. Here's its mechanism, research areas, and status.

A tuftsin analogue studied for anxiety, mood and cognition — without the sedation or dependence of benzodiazepines. Mechanism, research areas, and status.

A mitochondria-targeted research peptide that binds cardiolipin. Here's its mechanism, the areas it's been studied in, and its current research status.

A complete reference map: BPC-157, GHK-Cu, TB-500, KPV, AOD-9604, Tirzepatide, PT-141 and more — matched to the conditions they're being studied for.

One of the most researched compounds in tissue and gut repair science. Here's everything you need to know about BPC-157.

GHK-Cu is one of the most studied compounds in collagen synthesis, skin regeneration, and cellular repair. Here's the science.

Lipedema affects millions of women and remains poorly understood. Researchers are investigating several compounds for their potential role in managing the condition.

Lower doses, fewer side effects, and more sustainable protocols. Here's what the research shows about microdosing GLP-1 compounds.

MT-II is a non-selective melanocortin agonist studied for skin pigmentation, sexual function, and appetite regulation. Full research breakdown.

Derived from alpha-MSH, KPV targets NF-κB-driven inflammation with potent effects in gut, skin, and antimicrobial research at microgram doses.